As an industry innovator in DNA detection technology, Sequenom’s MassARRAY® Technology allows a direct and label-free measurement of nucleic acids by MALDI-TOF Mass Spectrometry, thus providing an unparalleled precision and sensitivity of genetic analysis in a multiplex reaction format.

MassARRAY® supports multiple applications: SNP Genotyping, Quantitative DNA Methylation, Quantitative Gene Expression or Comparative Sequence Analysis from low to high throughput can be studied on a single platform.

Sequenom is continuously refining these tools and has launched new applications for Copy Number Variation Analysis (CNV) or Oncogene Mutation Profiling (Onco Carta™). Sequenom is also developing a comprehensive portfolio of gene diagnostic tests. The high sensitivity of the technology allows detection of circulation cell-free fetal nucleic acids in a maternal blood sample. In 2010, laboratory diagnostic tests for cystic fibrosis carrier screen (CFTR), Fetal RhD and sex determination were introduced to the market.

Sequenom GmbH
Mendelssohnstr. 15D
D-22761 Hamburg, Germany
+49-(0)40 899 676 0
sales-europe@sequenom.com
www.sequenom.com